Expression of concern
The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone
Paper Information
Record ID:
20898
Author(s):
Journal:
Publication Date:
May 08, 2013
Retraction Date:
July 16, 2019
(6.4 years years ago)
Subjects:
Institutions:
- Laboratoire B2PE (Biologie et Pathologie du Pancréas Endocrine), Unité BFA (Biologie Fonctionnelle et Adaptive), Equipe 1, Université Paris-Diderot et CNRS EAC 4413, Bâtiment Buffon, 5éme étage, Piéce 552A, 4, rue Lagroua Weill Hallé, Case 7126, 75205 Paris Cedex 13, France
- OOO “NPF “MATERIA MEDICA HOLDING”, 3rd Samotyochny Per., 9, Moscow 127473, Russia
Article Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1155/2019/2938413Citations (21)
21
Total Citations4
Post-Retraction(19.0%)
16
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
3
After 2+ years
1812
Days since retraction (latest)
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jul 2024
1812 days after retraction
Echinacoside exerts its protective effects in a type 2 diabetes mellitus injury model via the AKT pathway
Wei‐Wei Ye, Meng Xiang-ying, Qian Zhao et al. (8 authors)
Journal of Asian Natural Products Research
Published: Dec 2022
4 citations
4 citations
1260 days after retraction
Therapeutic potential of highly diluted antibodies in antibiotic-resistant infection
А.Г. Емельянова, Н. В. Петрова, Christophe Fremez et al. (6 authors)
European Journal of Pharmaceutical Sciences
Open Access
Published: Mar 2022
12 citations
12 citations
962 days after retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jul 2020
379 days after retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jun 2019
30 days before retraction
Advanced approach to activity evaluation for released-active forms of antibodies to interferon-gamma by enzyme-linked immunoassay
Elena Don, Sergey А. Bobrovnik, Gordon Sherriff et al. (6 authors)
Journal of Immunoassay and Immunochemistry
Published: Jan 2019
10 citations
10 citations
177 days before retraction
Drug discovery today: no molecules required
Alexander Y. Panchin, Н. Н. Хромов-Борисов, Evgenia V. Dueva
BMJ evidence-based medicine
Published: Dec 2018
7 citations
7 citations
222 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Sep 2018
292 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Sep 2018
292 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Aug 2018
349 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jul 2017
745 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jan 2017
926 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jan 2017
926 days before retraction
The phenomenon of released‐activity. Reply on comment on Don et al.: Dose‐dependent antiviral activity of released‐active form of antibodies to interferon‐gamma against influenza A/California/07/09(H1N1) in murine model
Elena Don, Alexandra G. Emelyanova, N. N. Yakovleva et al. (9 authors)
Journal of Medical Virology
Published: Dec 2016
7 citations
7 citations
928 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Oct 2016
1018 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: May 2016
1161 days before retraction
In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form
Evgeniy A. Gorbunov, I. А. Ertuzun, Е. В. Качаева et al. (5 authors)
Neuropsychiatric Disease and Treatment
Open Access
Published: Nov 2015
13 citations
13 citations
1353 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Aug 2015
1445 days before retraction
Paper citing The Novel Oral Drug Subetta Exerts an Antidiabetic...
Unknown Authors
Unknown Journal
Published: Jul 2015
1476 days before retraction
Novel Approach to Activity Evaluation for Release-Active Forms of Anti-Interferon-Gamma Antibodies Based on Enzyme-Linked Immunoassay
E. Gavrilova, Sergey А. Bobrovnik, Gordon Sherriff et al. (6 authors)
PLoS ONE
Open Access
Published: May 2014
12 citations
12 citations
1894 days before retraction
Quick Stats
Total Citations:
21
Years Since Retraction:
6.4 years
Open Access:
Yes
Last Checked:
Never